DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Rab9 depletion enhances human adenovirus type 26 transduction efficiency through increased internalization and reduced late endosomal/lysosomal retention
Understanding intracellular trafficking is central to decoding viral pathogenesis and engineering optimized viral vectors. How a virus or vector is routed through the endocytic pathway directly dictates its genome release, immune sensing, and overall transduction efficiency. Human adenovirus type 26 (HAdV-D26) presents a promising platform for vector design due to its low preexisting immunity, potent immune stimulation, scalable production, and versatile genetic engineering capacity. Although increasingly significant, the fundamental mechanisms governing HAdV-D26 intracellular trafficking are still not fully understood. Our study demonstrates that compared to well-described human adenovirus type 5 (HAdV-C5), HAdV-D26 undergoes prolonged intracellular trafficking, transiently localizing to early endosomes before residing in late endosomes/lysosomes for up to four hours post-infection. Inhibition of lysosomal acidification modestly enhances HAdV-D26 transduction efficiency, whereas blocking transport from early to late endosomes/lysosomes does not. Strikingly, Rab9 knockdown reduces HAdV-D26 late endosomal/lysosomal localization while increasing both virus internalization and genome delivery to the host cell nucleus. These findings indicate that late endosomal sorting pathways actively influence HAdV-D26 infection outcomes. By identifying a previously unappreciated role for Rab9 in adenovirus transduction, our results provide new mechanistic insight into HAdV-D26 intracellular trafficking, highlight serotype-specific differences in adenovirus entry pathways, and identify endosomal trafficking steps that may be targeted to improve adenoviral vector performance., D.M. acknowledges funding from Croatia Science Foundation Research Projects (Grant IP-2019-04-6048 and IP-2025-02-3470 to D.M.); C.S.M. acknowledges funding from the Spanish State Research Agency, with co-funding from the European Regional Development Fund (PID2022-136456NB-I00/AEI/10.13039/501100011033). The C.S.M. group is a member of the Spanish Adenovirus Network (RED2022-134221-T/AEI/10.13039/501100011033). CNB-CSIC is an AEI Severo Ochoa Excellence Center (CEX2023-001386-S/AEI/10.13039/501100011033). Support from the European Commission Marie Skłodowska-Curie Actions (grant agreement 101129778, project INVECTA) to D.M. and C.S.M. is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2023-001386-S)., Peer reviewed
Proyecto:
AEI / Proyectos de I+D+i PID2022-136456NB-I00
,
AEI / Severo Ochoa CEX2023-001386-S
,
EC / HE 101129778
DOI: http://hdl.handle.net/10261/446817, https://api.elsevier.com/content/abstract/scopus_id/105047575941
HANDLE: http://hdl.handle.net/10261/446817, https://api.elsevier.com/content/abstract/scopus_id/105047575941